Abstract
Objective To evaluate the prognostic value of neutrophil-to-lymphocyte ratio (NLR) in patients with acute-on-chronic liver failure (ACLF) after glucocorticoid therapy. Methods Thirty-six patients with acute-on-chronic liver failure (ACLF) were treated with glucocorticoid therapy, of whom 23 patients in the survival group and the other in the deceased group (n=13). The changes of white blood cells, neutrophils, lymphocytes, NLR, total bilirubin (TBil), prothrombin activity (PTA), international normalized ratio (INR) were observed before, during and after treatment, and the relationship between NLR and prognosis was analyzed. Results NLR after glucocorticoid treatment, the survival group 3.95±2.65, the deceased group 12.79±10.66, there was significant difference between the two groups (P<0.001). According to univariate and multivariate logisitic regression analysis, NLR ratio was one of the independent factor in ACLF. ROC curve showed the AUC of NLR in patients with ACLF 0.868(95%CI: 0.743-0.993). After glucocorticoid treatment, the survival rate of NLR<3.315 patients with acute liver failure was high. Conclusions NLR is one of the important indexes for evaluating the prognosis of ACLF patients with ACLF due to glucocorticoid therapy. Key words: The neutrophil-to-lymphocyte ratio(NLR); Acute-on-chronic liver failure(ACLF); Predictive
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
